162 related articles for article (PubMed ID: 11048798)
1. Immunohistochemical and in situ hybridization analyses of midkine expression in thyroid papillary carcinoma.
Kato M; Maeta H; Kato S; Shinozawa T; Terada T
Mod Pathol; 2000 Oct; 13(10):1060-5. PubMed ID: 11048798
[TBL] [Abstract][Full Text] [Related]
2. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
3. Increased midkine expression in intrahepatic cholangiocarcinoma: immunohistochemical and in situ hybridization analyses.
Kato M; Shinozawa T; Kato S; Endo K; Terada T
Liver; 2000 Jun; 20(3):216-21. PubMed ID: 10902971
[TBL] [Abstract][Full Text] [Related]
4. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
[TBL] [Abstract][Full Text] [Related]
5. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.
Kamoshida S; Ogane N; Yasuda M; Muramatsu T; Bessho T; Kajiwara H; Osamura RY
Mod Pathol; 2000 Jul; 13(7):736-41. PubMed ID: 10912932
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization.
Tanaka K; Inoue H; Miki H; Komaki K; Monden Y
Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520
[TBL] [Abstract][Full Text] [Related]
8. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.
Cheng S; Liu W; Mercado M; Ezzat S; Asa SL
Endocr Relat Cancer; 2009 Jun; 16(2):455-66. PubMed ID: 19261683
[TBL] [Abstract][Full Text] [Related]
9. Increased midkine expression in hepatocellular carcinoma.
Kato M; Shinozawa T; Kato S; Awaya A; Terada T
Arch Pathol Lab Med; 2000 Jun; 124(6):848-52. PubMed ID: 10835519
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein e expression in anaplastic thyroid carcinoma.
Ito Y; Takano T; Miyauchi A
Oncology; 2006; 71(5-6):388-93. PubMed ID: 17690558
[TBL] [Abstract][Full Text] [Related]
11. Expression and significance of c-met protein in papillary thyroid carcinoma.
Inaba M; Sato H; Abe Y; Umemura S; Ito K; Sakai H
Tokai J Exp Clin Med; 2002 Aug; 27(2):43-9. PubMed ID: 12472169
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.
Saiz AD; Olvera M; Rezk S; Florentine BA; McCourty A; Brynes RK
J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the HIP gene coding for a heparin/heparan sulfate-binding protein in human thyroid carcinomas.
de Nigris F; Visconti R; Cerutti J; Califano D; Mineo A; Santoro M; Santelli G; Fusco A
Cancer Res; 1998 Oct; 58(20):4745-51. PubMed ID: 9788632
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
[TBL] [Abstract][Full Text] [Related]
15. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma.
Baek SK; Woo JS; Kwon SY; Lee SH; Chae YS; Jung KY
Laryngoscope; 2007 May; 117(5):911-6. PubMed ID: 17473695
[TBL] [Abstract][Full Text] [Related]
17. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
18. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
20. Induction of midkine expression in reactive astrocytes following rat transient forebrain ischemia.
Mochizuki R; Takeda A; Sato N; Kimpara T; Onodera H; Itoyama Y; Muramatsu T
Exp Neurol; 1998 Jan; 149(1):73-8. PubMed ID: 9454616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
